These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 21262501)
1. Reducing vascular disease risk in the type 2 diabetic patient. Brown WV; Goldberg RB; Lopes-Virella M; Reaven P J Clin Lipidol; 2011; 5(1):3-11. PubMed ID: 21262501 [No Abstract] [Full Text] [Related]
2. [Obesity and cardiovascular morbidity]. Berg A; Bönner G Dtsch Med Wochenschr; 2005 Apr; 130(14):893-7. PubMed ID: 15800824 [No Abstract] [Full Text] [Related]
3. [Management of patients with essential hypertension. Clinical recommendations and economic data. Guidelines April 2000. Recommendations of the ANAES]. Agence Nationale d'Accréditation et d'Evaluation en Santé J Mal Vasc; 2000 Dec; 25(5):366-376. PubMed ID: 11148400 [No Abstract] [Full Text] [Related]
5. Current pharmacotherapeutic concepts for the treatment of cardiovascular disease in diabetics. Highlander P; Shaw GP Ther Adv Cardiovasc Dis; 2010 Feb; 4(1):43-54. PubMed ID: 19965897 [TBL] [Abstract][Full Text] [Related]
6. Optimal diabetes management during medical weight loss for cardiovascular risk reduction. Nori Janosz KE; Miller WM; Odom J; Lillystone M; McCullough PA Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):761-75. PubMed ID: 16076284 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of vascular disease in hypertension with special reference to diabetes. Yudkin JS Semin Vasc Med; 2002 May; 2(2):139-48. PubMed ID: 16222605 [TBL] [Abstract][Full Text] [Related]
8. [Type 2 diabetes and cardiovascular risk: lessons from therapeutic trials]. Lièvre M Rev Prat; 2001 Oct; 51(16):1793-9. PubMed ID: 11795124 [TBL] [Abstract][Full Text] [Related]
9. Endothelial dysfunction and hypertension in diabetes mellitus. Dandona P; Chaudhuri A; Aljada A Med Clin North Am; 2004 Jul; 88(4):911-31, x-xi. PubMed ID: 15308385 [TBL] [Abstract][Full Text] [Related]
10. Recommendations from the Canadian Diabetes Association. 2003 guidelines for prevention and management of diabetes and related cardiovascular risk factors. Harris SB; Lank CN Can Fam Physician; 2004 Mar; 50():425-33. PubMed ID: 15318682 [No Abstract] [Full Text] [Related]
11. Lifestyle modification and endothelial function in obese subjects. Hamdy O Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597 [TBL] [Abstract][Full Text] [Related]
12. [Antihypertensive treatment in type II diabetes and diabetic nephropathy]. Chantrel F; Bouiller M; Kolb I; Hannedouche T Nephrologie; 2000; 21(2):47-55. PubMed ID: 10798204 [TBL] [Abstract][Full Text] [Related]
13. [Evaluation and care of patients with type Ii diabetes regarding recommendations concerning cardiovascular risk factors and adherence to values in general medicine in the Grand Duchy of Luxembourg]. Stein R; Aubart-Schuller M; Vandenberghe H Bull Soc Sci Med Grand Duche Luxemb; 2010; (2):289-301. PubMed ID: 20882748 [TBL] [Abstract][Full Text] [Related]
14. Are plasma lipoproteins responsible for the excess atherosclerosis in diabetes? Nikkilä EA Acta Endocrinol Suppl (Copenh); 1985; 272():27-30. PubMed ID: 3869424 [TBL] [Abstract][Full Text] [Related]
15. ACCORD and Risk-Factor Control in Type 2 Diabetes. Nilsson PM N Engl J Med; 2010 Apr; 362(17):1628-30. PubMed ID: 20228405 [No Abstract] [Full Text] [Related]
16. Is family history a useful tool for detecting children at risk for diabetes and cardiovascular diseases? A public health perspective. Valdez R; Greenlund KJ; Khoury MJ; Yoon PW Pediatrics; 2007 Sep; 120 Suppl 2():S78-86. PubMed ID: 17767009 [TBL] [Abstract][Full Text] [Related]